Patent intelligence · US
US 9731037
Scanning suspension comprising a particle with a diameter of at least 1 micrometer
Scanning suspension comprising a particle with a diameter of at least 1 micrometer
Patent details — US 9731037
- Jurisdiction
- US
- Status
- granted
- Grant date
- Aug 15, 2017
- Expiration
- Aug 10, 2037
- Applicant
- Universitair Medisch Centrum Utrecht
- Claims
- 9
- CPC classes
- A61K, A61K33/24, A61K49/00, A61K49/1821
Quick answer
US 9731037 (Scanning suspension comprising a particle with a diameter of at least 1 micrometer) is held by Universitair Medisch Centrum Utrecht. Status: granted. Granted Aug 15, 2017. Expires Aug 10, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Universitair Medisch Centrum Utrecht
- Grant date
- Expiration
- Claims
- 9
- CPC classes
- A61K, A61K33/24, A61K49/00, A61K49/1821, A61K51/1255, A61K51/1282
More from Universitair Medisch Centrum Utrecht
Related pharmaceutical patents in our USPTO index.
-
US 12427173
Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-CTLA-4 and/or anti-PD-1 antibodies to treat solid tumor malignancies
granted -
US 12428415
Matriptase 2 inhibitors and uses thereof
granted -
US 12421236
Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor
granted -
US 12420085
Synergistic therapies for inter vertebral disc degeneration
granted -
US 12421231
Azaindole derivatives and their use as ERK kinase inhibitors
granted -
US 12403069
Adapter for use in a planetary mixer
granted -
US 12398179
Nanomolar peptides and derivatives to differentially modulate ephrin receptors
granted -
US 12396924
Adapter for use in a planetary mixer
granted
Frequently asked questions
What is US patent 9731037?
US 9731037 (Scanning suspension comprising a particle with a diameter of at least 1 micrometer) is held by Universitair Medisch Centrum Utrecht. Status: granted. Granted Aug 15, 2017. Expires Aug 10, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9731037?
Universitair Medisch Centrum Utrecht is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 706 pharmaceutical patents for this assignee.
When does US 9731037 expire?
Our index shows an expiration date of Aug 10, 2037 (11 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.